Robert A. Copeland, President of Research and CSO at Epizyme, Inc. (EPZM), sold 8,000 shares at $10.37 ($83K) on 2016-08-01, disclosed to the SEC on 2016-08-03.
Open-market sale of $83k EPZM by President of Research and CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.37 | 4,000 | $41K | 50.0% |
| 2 | $10.37 | 4,000 | $41K | 50.0% |
| Total | $10.37 avg | 8,000 | $83K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |
| EPZM | SELL | 2016-01-04 | $130K | — | Filing → |